Table 5 Baseline characteristics of the CRC patients with liver metastasis
Variables, N (%) | mCRC (N = 432) |
|---|---|
Synchronous metastasis | |
 Yes | 271 |
 No | 161 |
Gender | |
 Male | 237 |
 Female | 195 |
Age, years | 57.6 ± 11.3 |
TNM stage | |
 I | 14 |
 II | 48 |
 III | 99 |
 IV | 271 |
T stage | |
 T1 | 13 |
 T2 | 39 |
 T3 | 132 |
 T4 | 248 |
N stage | |
 N0 | 161 |
 N1 | 172 |
 N2 | 99 |
CRS | |
 ≤ 2 | 237 |
 > 2 | 195 |
Size of largest liver metastasis (cm) | 3.05 ± 1.8 |
No. of liver metastasis | 3 ± 2 |
Neo-adjuvant chemotherapy | 246 |
Location | |
 Right-sided colon | 109 |
 Left-sided colon | 114 |
 Rectum | 209 |
Histological type | |
 Adenocarcinoma | 414 |
 Mucinous | 18 |
Lymph node examined | |
 Median | 15 ± 7 |
Perineural invasion | |
 Negative | 308 |
 Positive | 124 |
Vascular invasion | |
 Negative | 309 |
 Positive | 123 |
Therapy | |
 Surgery | 305 |
 Ablation | 127 |
 Diabetes mellitus | 43 |
 Obesity (BMI > 25) | 88 |
 CEA (ng/mL) | 40.7 ± 95 |